Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

90.00p
   
  • Change Today:
    -0.100p
  • 52 Week High: 92.05p
  • 52 Week Low: 47.52p
  • Currency: UK Pounds
  • Shares Issued: 966.40m
  • Volume: 911,895
  • Market Cap: £869.76m
  • Beta: 0.03

Latest Deals

Traded Action Notifier PriceAmountValue
01-Sep-25 Sell Giles Wilson 91.08p 30,000 £27,324.69
01-Sep-25 Buy Giles Wilson 91.15p 30,019 £27,360.73
01-Sep-25 Sell Giles Wilson 89.65p 105,785 £94,836.25
01-Sep-25 Buy Giles Wilson 91.38p 105,838 £96,711.59

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
01-Sep-25 Buy Giles Wilson 91.38p 105,838 £96,711.59
01-Sep-25 Sell Giles Wilson 89.65p 105,785 £94,836.25
01-Sep-25 Buy Giles Wilson 91.15p 30,019 £27,360.73
01-Sep-25 Sell Giles Wilson 91.08p 30,000 £27,324.69

Director Shareholdings

Notifier Holding Value*
Paul Mason 7,875,000 £7,087,500
Giles Wilson 230,193 £207,174
Robyn Perriss 94,328 £84,895
Andrew Harrison 76,594 £68,935
Lynne Weedall 40,054 £36,049
Ian Rogers 20,270 £18,243
Ije Nwokori 6,559 £5,903

Major Shareholders

Notifier** Holding Value*
IngreLux S.àr.l 369,942,440 £332,948,196
IngreGrsy Limited 369,942,440 £332,948,196
Permira Holdings Limited 364,142,440 £327,728,196
Artemis Investment Management LLP 86,997,521 £78,297,769
Fidelity Management & Research 32,500,000 £29,250,000
Intertrust Employee Benefit Trustee Limited 135,000 £121,500

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 90.00p
Change Today -0.100p
% Change -0.11 %
52 Week High 92.05p
52 Week Low 47.52p
Volume 911,895
Shares Issued 966.40m
Market Cap £869.76m
Beta 0.03

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average28.38% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Trend
32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average32.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average48.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average99.52% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Aug-25 06-Mar-25
Paid 08-Oct-25 08-Apr-25
Amount 1.70p 0.85p

Trades for 10-Sep-2025

Time Volume / Share Price
15:16 4 @ 89.40p
16:39 25,000 @ 90.00p
16:35 566,533 @ 90.00p
16:35 1 @ 90.00p
16:35 3,808 @ 90.00p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page